Spending by Commercial Insurers on Chemotherapy Based on Site of Care, 2004-2014. JAMA Oncol 2018 Apr 01;4(4):580-581
Date
02/23/2018Pubmed ID
29470578Pubmed Central ID
PMC5885220DOI
10.1001/jamaoncol.2017.5544Scopus ID
2-s2.0-85047481278 (requires institutional sign-in at Scopus site) 18 CitationsAbstract
This database study analyzes trends in infused chemotherapy services performed in the physician office or hospital outpatient setting for commercially insured patients with cancer.
Author List
Winn AN, Keating NL, Trogdon JG, Basch EM, Dusetzina SBMESH terms used to index this publication - Major topics in bold
Antineoplastic AgentsCancer Care Facilities
Commerce
Databases, Factual
Drug Costs
Female
Health Expenditures
Humans
Insurance Carriers
Insurance Claim Review
Insurance, Health
Male
Outpatient Clinics, Hospital
Physicians' Offices
Product Surveillance, Postmarketing
Retrospective Studies
United States